Scoop: Bob Nelsen is building a Really Big Neuroscience Company
Over the last year, ARCH managing director Bob Nelsen has been quietly raising hundreds of millions of dollars to launch a massive neuroscience-focused biotech.
The company has been filing documents out of ARCH’s San Francisco office since at least May of 2020. Fittingly for Nelsen — the venture capitalist who initially christened the CAR-T company Juno “Fuck Cancer” and the cell therapy behemoth Sana “Fuck Disease” — the biotech is operating under a codename: RBNC Therapeutics. It stands, a source said, for Really Big Neuroscience Company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.